CANKADO Patient App is made and published by CANKADO. AppBrain is an independent app data site and isn't affiliated with CANKADO. The app name, icon, screenshots and description belong to CANKADO and are shown as published on the App Store.
AppBrain's verdict
Established- Rating on App Store
- 5.00
- 1 ratings
- Last updated
- September 24, 2026
It doesn't have enough ratings yet to judge what users think.
Rankings
App Store top chartsApp Store Rankings for CANKADO Patient App
Competitors
Similar apps and more from CANKADOAlternatives to CANKADO Patient App
More from CANKADO
Releases
Updates seen on the App Store- Version
- 7.6
- Launched
- February 2018
No changelog data
User feedback
Ratings and reviews on the App StoreComments on CANKADO Patient App for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 38.9 MB
- Content rating
- Medium
Technologies used by CANKADO Patient App
About the app and developer
About CANKADO Patient App
CANKADO Patient App is a medical app developed by CANKADO.
What is the rating of CANKADO Patient App?
CANKADO Patient App is rated 5.00 out of 5 stars, based on one rating ratings.
Is CANKADO Patient App free?
CANKADO Patient App is free. The app size is 38.91 MB. The latest version available is 7.6. The last update was on September 24, 2026.
What are the requirements for CANKADO Patient App?
The app has a content rating of Medium Maturity. The app has been available on the App Store since February 2018.
Developer information for CANKADO
Address:
Store listing
By CANKADO, from the App Store
Description by CANKADO Written by the developer, not by AppBrain. Click to read.
The application is specifically designed for use in conjunction with a medical center. This applies to both routine care and use in clinical trials. All functions are only activated when connected to a center. Without such a connection, only fundamental functions are available.
The focus is on the PRO-React module. This module is registered in the European Union as a Class I medical device. The large prospective, randomized, multicenter PreCycle study showed that PRO-React can reduce the incidence of serious adverse events (SAE). Quality of life improves, and unplanned interruptions to therapy occur less frequently. The most important results are published in Harbeck N et al Cancer Treat Rev 2023 Dec;121:102631 and Harbeck N et al Ann Oncol 2023 Aug;34(8):660-669. The Gynaecological Oncology Working Group (AGO) of the German Cancer Society has included PRO-React with evidence level A+ in its general supportive care guidelines for breast cancer.
The app supports communication with your center and provides notifications when your health status changes. This allows adverse trends to be identified at an early stage.
Main functions at a glance
· New, clear design with completely revised user guidance
· Recording of symptoms, Quality of life, Medication intake, and other information
· PRO-React with automated analysis of your information and early notifications
· Advanced functions are only available after activation by the medical center
· Data protection and data security in accordance with European requirements
· Use in routine care and clinical trials
Disclaimer:
CANKADO does not replace direct contact with your physician! Please contact your physician as soon as you have any questions or difficulties. Always follow your physician's instructions.